The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Clinical trial NCT06383390 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06383390
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)

Start date: 2024-04-30
Primary completion: 2029-02-01
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.